Stomach Cancer Trial, Recruiting NCT07098026 Sponsor: Hunan Cancer Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07098026
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a specific type of stomach or stomach-oesophagus junction cancer (called adenocarcinoma), confirmed by tissue or cell testing
  • People whose cancer is removable by surgery, or potentially removable, and has reached a certain stage of spread within the local area but has not spread to distant parts of the body
  • People who have not previously received any cancer treatments such as chemotherapy, radiation, immunotherapy, or targeted therapy
  • People whose blood counts, liver function, kidney function, and protein levels fall within acceptable ranges as measured by blood tests (confirm specific values with trial site)
  • People who score 70 or above on a general health and ability scale called the Karnofsky Performance Scale, meaning they are reasonably able to carry out normal daily activities
  • People aged between 18 and 75 years, male or female
  • People who are willing to sign a written consent form agreeing to take part in the trial

Who may not be able to join:

  • People whose cancer has spread to distant parts of the body
  • People with a known allergy or sensitivity to fluorouracil or oxaliplatin (chemotherapy drugs), or to the study drug being tested
  • People who currently have another type of cancer elsewhere in the body (exceptions may apply for people who have been cancer-free for 5 years, have had certain skin cancers fully removed, or have had certain early-stage cancers successfully treated — confirm with trial site)
  • People experiencing urgent stomach or bowel problems such as difficulty swallowing, blockage of the bowel, bleeding in the digestive tract, or a hole in the digestive tract
  • People who are pregnant, or who have a neurological condition, a mental illness, or a communication or language difficulty
  • People with serious heart conditions such as uncontrolled chest pain, irregular heartbeat, heart failure, or a heart attack — particularly if a heart-related event occurred within the 6 months before joining the trial
  • People with any other serious medical condition that could make participation unsafe or interfere with the trial results
  • People who are not legally able to consent, or for whom continuing the trial would be inappropriate for medical or ethical reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618811732383

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hunan Cancer Hospital
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

EFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov